Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s...
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a analysis
About this item
Full title
Author / Creator
Publisher
SAGE Publishing
Journal title
Language
English
Formats
Publication information
Publisher
SAGE Publishing
More information
Scope and Contents
Contents
Background: Matrix metalloproteinase-9 (MMP-9) is a novel marker of intestinal inflammation. The aim of this study was to assess if serum MMP-9 levels predict clinical flare in patients with quiescent Crohn’s disease (CD). Methods: This study was a post hoc analysis of a prospective observational study in which quiescent CD patients were included a...
Alternative Titles
Full title
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn’s disease, a analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_98c632aad8d54fd8a4064f37087b4dc8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_98c632aad8d54fd8a4064f37087b4dc8
Other Identifiers
E-ISSN
1756-2848
DOI
10.1177/1756284819881590